Development and validation of the food allergy severity score

. 2022 May ; 77 (5) : 1545-1558. [epub] 20211112

Jazyk angličtina Země Dánsko Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid34716996

Grantová podpora
MR/K010468/1 Medical Research Council - United Kingdom

BACKGROUND: The heterogeneity and lack of validation of existing severity scores for food allergic reactions limit standardization of case management and research advances. We aimed to develop and validate a severity score for food allergic reactions. METHODS: Following a multidisciplinary experts consensus, it was decided to develop a food allergy severity score (FASS) with ordinal (oFASS) and numerical (nFASS) formats. oFASS with 3 and 5 grades were generated through expert consensus, and nFASS by mathematical modeling. Evaluation was performed in the EuroPrevall outpatient clinic cohort (8232 food reactions) by logistic regression with request of emergency care and medications used as outcomes. Discrimination, classification, and calibration were calculated. Bootstrapping internal validation was followed by external validation (logistic regression) in 5 cohorts (3622 food reactions). Correlation of nFASS with the severity classification done by expert allergy clinicians by Best-Worst Scaling of 32 food reactions was calculated. RESULTS: oFASS and nFASS map consistently, with nFASS having greater granularity. With the outcomes emergency care, adrenaline and critical medical treatment, oFASS and nFASS had a good discrimination (receiver operating characteristic area under the curve [ROC-AUC]>0.80), classification (sensitivity 0.87-0.92, specificity 0.73-0.78), and calibration. Bootstrapping over ROC-AUC showed negligible biases (1.0 × 10-6 -1.23 × 10-3 ). In external validation, nFASS performed best with higher ROC-AUC. nFASS was strongly correlated (R 0.89) to best-worst scoring of 334 expert clinicians. CONCLUSION: FASS is a validated and reliable method to measure severity of food allergic reactions. The ordinal and numerical versions that map onto each other are suitable for use by different stakeholders in different settings.

Allergy Clinic Copenhagen University Hospital at Herlev Gentofte Copenhagen Denmark

Allergy Department 2nd Pediatric Clinic University of Athens Athens Greece

Allergy Department Hospital Clínico San Carlos Facultad de Medicina Universidad Complutense IdISSC ARADyAL Madrid Spain

Allergy Department Hospital Clínico San Carlos IdISSC ARADyAL Madrid Spain

Allergy Department Sotiria Chest Diseases Hospital Athens Greece

Allergy Division Chest Disease Department University Hospital of Strasbourg Strasbourg France

Allergy Dpt 2nd Pediatric clinic University of Athens Athens Greece

Ambulatorio di Allergologia Clinica San Carlo Paderno Dugnano Milan Italy

Chest Diseases Department Strasbourg University Hospital Federation of Translational Medicine University of Strasbourg Strasbourg France

Children's Hospital and Department of Allergy Landspitali University Hospital Reykjavik Iceland

Clinic for Dermatology and Allergology Kantonsspital St Gallen St Gallen Switzerland

Clinic of Allergy and Asthma Medical University in Sofia Sofia Bulgaria

Clinical and Experimental Sciences and Human Development in Health Faculty of Medicine University of Southampton Southampton UK

Clinical and Experimental Sciences Faculty of Medicine University of Southampton Southampton UK

Department of Allergy and Immunology Medical University of Lodz Lodz Poland

Department of Clinical Immunology and Allergy Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester UK

Department of Dermatology University Hospital Zurich Zurich Switzerland

Department of Dietetics Salford Royal NHS Foundation Trust Salford UK

Department of Experimental Immunology and Department of Clinical Epidemiology Biostatistics and Bioinformatics Amsterdam University Medical Center Amsterdam The Netherlands

Department of Pathophysiology and Allergy Research Medical University of Vienna Vienna Austria

Department of Pediatric Respiratory Medicine Immunology and Intensive Care Medicine Charité Universitätsmedizin Berlin Berlin Germany

Departments of Experimental Immunology and of Otorhinoraryngology Amsterdam University Medical Centers Amsterdam The Netherlands

Dept Dermatology Allergology University Medical Center Utrecht Utrecht University Utrecht The Netherlands

Division of Allergy and Immunology Department of Dermatology Venerology and Allergology Charité Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin Humboldt Universität zu Berlin and Berlin Institute of Health Berlin Germany

Division of Infection Immunity and Respiratory Medicine Manchester Academic Health Sciences Centre Manchester Institute of Biotechnology University of Manchester Manchester UK

Division of Infection Immunity and Respiratory Medicine School of Biological Sciences Manchester Academic Health Science Centre NIHR Manchester Biomedical Research Centre and Manchester University NHS Foundation Trust The University of Manchester Manchester UK

Division of Infection Immunity and Respiratory Medicine University of Manchester Manchester UK

Food Allergy Referral Centre Veneto Region Department of Women and Child Health Padua General University Hospital Padua Italy

Grupo de Investigación en Alergia IdISSC Madrid Spain

Institute of Immunity and Transplantation Royal Free Hospital and University College London London UK

Medical Faculty and Faculty Hospital Pilsen Pilsen Czech Republic

Medical Faculty Vilnius University Vilnius Lithuania

National Heart and Lung Institute Imperial College London London UK

NIHR Southampton Biomedical Research Centre University Hospital Southampton NHS Foundation Trust Southampton UK

Preventive Medicine Department Complejo Hospitalario Universitario Santiago de Compostela Santiago de Compostela Spain

Preventive Medicine Department Hospital Clínico San Carlos IdISSC Madrid Spain

Royal College of Surgeons in Ireland Children's Health Ireland at Temple Street Dublin Ireland

Srebrnjak Children's Hospital Zagreb Catholic University of Croatia Zagreb and Medical Faculty Osijek J J Strossmayer University Osijek Croatia

The David Hide Asthma and Allergy Research Centre St Mary's Hospital Isle of Wight UK

Unidad de Apoyo a la Investigación Preventive Medicine Department Hospital Clínico San Carlos IdISSC Universidad Alfonso 10 El Sabio Madrid Spain

University Hospital Sv Ivan Rilski Sofia Bulgaria

Zobrazit více v PubMed

Nwaru BI, Hickstein L, Panesar SS, et al. Prevalence of common food allergies in Europe: a systematic review and meta‐analysis. Allergy. 2014;69:992‐1007. 10.1111/all.12423 PubMed DOI

Dunlop JH, Keet CA. Epidemiology of food allergy. Immunol Allergy Clin North Am. 2018;38:13‐25. 10.1016/j.iac.2017.09.002 PubMed DOI

Panesar SS, Javad S, de Silva D, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353‐1361. 10.1111/all.12272 PubMed DOI

Worm M, Moneret‐Vautrin A, Scherer K, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69:1397‐1404. 10.1111/all.12475 PubMed DOI

Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis‐related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015;135:956‐963. 10.1016/j.jaci.2014.10.021 PubMed DOI PMC

Tejedor‐Alonso MA, Moro‐Moro M, Mosquera González M, et al. Increased incidence of admissions for anaphylaxis in Spain 1998–2011. Allergy. 2015;70:880‐883. 10.1111/all.12613 PubMed DOI

Grabenhenrich LB, Dölle S, Moneret‐Vautrin A, et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016;137:1128‐1137. 10.1016/j.jaci.2015.11.015 PubMed DOI

Turner PJ, Baumert JL, Beyer K, et al. Can we identify patients at risk of life‐threatening allergic reactions to food? Allergy. 2016;71:1241‐1255. 10.1111/all.12924 PubMed DOI

Muraro A, Werfel T, Hoffmann‐Sommergruber K, et al. Diagnosis and management of food allergy. Allergy. 2014;69:1008‐1025. 10.1111/all.12429 PubMed DOI

DunnGalvin A, Blumchen K, Timmermans F, et al. APPEAL‐1: a multiple‐country European survey assessing the psychosocial impact of peanut allergy. Allergy. 2020;75:2899‐2908. 10.1159/000375106 PubMed DOI PMC

Crevel RWR, Baumert JL, Baka A, et al. Development and evolution of risk assessment for food allergens. Food Chem Toxicol. 2014;67:262‐276. 10.1016/j.fct.2014.01.032 PubMed DOI

Dubois AEJ, Turner PJ, Hourihane J, et al. How does dose impact on the severity of food‐induced allergic reactions, and can this improve risk assessment for allergenic foods?: Report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop. Allergy. 2018;73:1383‐1392. 10.1111/all.13405 PubMed DOI PMC

Pajno GB, Fernandez‐Rivas M, Arasi S, et al. EAACI Guidelines on allergen immunotherapy: IgE‐mediated food allergy. Allergy. 2018;73:799‐815. 10.1111/all.13319 PubMed DOI

PALISADE Group of Clinical Investigators , Vickery BP, Vereda A, et al. AR101 oral immunotherapy for peanut allergy. N Engl J Med. 2018;22(379):1991‐2001. 10.1056/NEJMoa1812856 PubMed DOI

Fleischer DM, Greenhawt M, Sussman G, et al. Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial. JAMA. 2019;321:946‐955. 10.1001/jama.2019.1113 PubMed DOI PMC

Nicolaides RE, Parrish CP, Bird JA. Food allergy immunotherapy with adjuvants. Immunol Allergy Clin North Am. 2020;40:149‐173. 10.1016/j.iac.2019.09.004 PubMed DOI

Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114:371‐376. 10.1016/j.jaci.2004.04.029 PubMed DOI

Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1:466‐469. 10.1016/s0140-6736(77)91953-5 PubMed DOI

Ring J. Anaphylactoid reactions to intravenous solutions used for volume substitution. Clin Rev Allergy. 1991;9:397‐414. 10.1007/BF02802316 PubMed DOI

Ring J, Behrendt H. Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology. Clin Rev Allergy Immunol. 1999;17:387‐399. 10.1007/BF02737644 PubMed DOI

Mueller HL. Further experiences with severe allergic reactions to insect stings. N Engl J Med. 1959;261:374‐377. 10.1056/NEJM195908202610803 PubMed DOI

Lockey RF, Turkeltaub PC, Baird‐Warren IA, et al. The Hymenoptera venom study I, 1979–1982: demographics and history‐sting data. J Allergy Clin Immunol. 1988;82:370‐381. 10.1016/s0091-6749(05)80182-4 PubMed DOI

Reisman RE. Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re‐sting reactions. J Allergy Clin Immunol. 1992;90:335‐339. 10.1016/s0091-6749(05)80012-0 PubMed DOI

Golden DB, Kwiterovich KA, Kagey‐Sobotka A, Lichtenstein LM. Discontinuing venom immunotherapy: extended observations. J Allergy Clin Immunol. 1998;101:298‐305. 10.1016/S0091-6749(98)70239-8 PubMed DOI

Hourihane JO, Kilburn SA, Dean P, Warner JO. Clinical characteristics of peanut allergy. Clin Exp Allergy. 1997;27:634‐639. 10.1111/j.1365-2222.1997.tb01190.x PubMed DOI

Hourihane JO'B, Grimshaw KEC, Lewis SA, et al. Does severity of low‐dose, double‐blind, placebo‐controlled food challenges reflect severity of allergic reactions to peanut in the community? ClinExp Allergy. 2005;35:1227‐1233. 10.1111/j.1365-2222.2005.02312.x PubMed DOI

Ewan PW, Clark AT. Long‐term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet. 2001;357:111‐115. 10.1016/s0140-6736(00)03543-1 PubMed DOI

Sampson HA. Anaphylaxis and emergency treatment. Pediatrics. 2003;111:1601‐1608. PMID: 12777599. PubMed

Astier C, Morisset M, Roitel O, et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol. 2006;118:250‐256. 10.1016/j.jaci.2006.04.053 PubMed DOI

Cianferoni A, Garrett JP, Naimi DR, Khullar K, Spergel JM. Predictive values for food challenge‐induced severe reactions: development of a simple food challenge score. Isr Med Assoc J. 2012;14:24‐28. PMID: 22624438. PubMed

Hino A, Maeda T, Haneda Y, et al. [Establishment of "Anaphylaxis Scoring Aichi (ASCA)," a new symptom scoring system to be used in an oral food challenge (OFC)]. Arerugi. 2013;62:968‐979. PMID: 24335424 PubMed

Niggemann B, Beyer K. Time for a new grading system for allergic reactions? Allergy. 2016;71:135‐136. 10.1111/all.12765 PubMed DOI

Dribin TE, Schnadower D, Spergel JM, et al. Severity grading system for acute allergic reactions: A multidisciplinary Delphi study. J Allergy Clin Immunol. 2021;148(21):00047‐56. 10.1016/j.jaci.2021.01.003 PubMed DOI PMC

Bernstein DI, Epstein T, Murphy‐Berendts K, Liss GM. Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study. Ann Allergy Asthma Immunol. 2010;104:530‐535. 10.1016/j.anai.2010.04.008 PubMed DOI PMC

Cox L, Larenas‐Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010;125(569–74):574.e1‐574.e7. 10.1016/j.jaci.2009.10.060 PubMed DOI

Cox LS, Sanchez‐Borges M, Lockey RF. World allergy organization systemic allergic reaction grading system: is a modification needed? J Allergy Clin Immunol Pract. 2017;5:58‐62.e5. 10.1016/j.jaip.2016.11.009 PubMed DOI

Epstein TG, Liss GM, Murphy‐Berendts K, Bernstein DI. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008–2012: an update on fatal and nonfatal systemic allergic reactions. J Allergy Clin Immunol Pract. 2014;2:161‐167. 10.1016/j.jaip.2014.01.004 PubMed DOI

Eller E, Muraro A, Dahl R, Mortz CG, Bindslev‐Jensen C. Assessing severity of anaphylaxis: a data‐driven comparison of 23 instruments. Clin Transl Allergy. 2018;8:29. 10.1186/s13601-018-0215-x PubMed DOI PMC

Vidal C, Rodríguez del Río P, Gude F, et al. Comparison of international systemic adverse reactions due to allergen immunotherapy. J Allergy Clin Immunol Pract. 2019;7:1298‐1305.e3. 10.1016/j.jaip.2018.12.006 PubMed DOI

Arasi S, Nurmatov U, Dunn‐Galvin A, et al. Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review. World Allergy Organ J. 2021;14(3):100503. 10.1016/j.waojou.2020.100503 PubMed DOI PMC

Muraro A, Fernandez‐Rivas M, Beyer K, et al. The urgent need for a harmonized severity scoring system for acute allergic reactions. Allergy. 2018;73:1792‐1800. 10.1111/all.13408. PubMed DOI

Moons KGM, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1‐73. 10.7326/M14-0698 PubMed DOI

Sampson HA, Gerth van Wijk R, Bindslev‐Jensen C, et al. Standardizing double‐blind, placebo‐controlled oral food challenges: American Academy of Allergy, Asthma & Immunology‐European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol. 2012;130:1260‐1274. 10.1016/j.jaci.2012.10.017 PubMed DOI

Fernández‐Rivas M, Barreales L, Mackie AR, et al. The EuroPrevall outpatient clinic study on food allergy: background and methodology. Allergy. 2015;70:576‐584. 10.1111/all.12585 PubMed DOI

Kummeling I, Mills ENC, Clausen M, et al. The EuroPrevall surveys on the prevalence of food allergies in children and adults: background and study methodology. Allergy. 2009;64:1493‐1497. 10.1111/j.1398-9995.2009.02046.x PubMed DOI

Roberts G, Allen K, Ballmer‐Weber B, et al. Identifying and managing patients at risk of severe allergic reactions to food: report from two iFAAM workshops. Clin Exp Allergy. 2019;49:1558‐1566. 10.1111/cea.13516 PubMed DOI

Grabenhenrich LB, Reich A, Bellach J, et al. A new framework for the documentation and interpretation of oral food challenges in population‐based and clinical research. Allergy. 2017;72:453‐461. 10.1111/all.13049 PubMed DOI PMC

Fernández‐Rivas M, Bolhaar S, González‐Mancebo E, et al. Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. J Allergy Clin Immunol. 2006;118:481‐488. 10.1016/j.jaci.2006.05.012 PubMed DOI

Flynn TN, Marley AAJ. Best‐worst scaling: stheory and methods. In: Hess S, Daly A, eds. Handbook of Choice Modelling. Edward Elgar Publishing; 2014:178‐201.

Stafford A, Bartra J, Aston A, et al. Improving severity scoring of food‐induced allergic reactions: a global “Best‐Worst Scaling” exercise. J Allergy Clin Immunol Pract, 2021. (in press). 10.1016/j.jaip.2021.06.056 PubMed DOI PMC

Lemeshow S, Le Gall JR. Modelling the severity of illness of ICU patients. A systems update. JAMA. 1994;272:1049‐1055. PMID: 8089888. PubMed

Grabenhenrich LB, Dölle S, Ruëff F, et al. Epinephrine in severe allergic reactions: The European Anaphylaxis Register. J Allergy Clin Immunol Pract. 2018;6:1898‐1906. 10.1016/j.jaip.2018.02.026 PubMed DOI

Capps JA, Sharma V, Arkwright PD. Prevalence, outcome and pre‐hospital management of anaphylaxis by first aiders and paramedical ambulance staff in Manchester, UK. Resuscitation. 2010;81:653‐657. 10.1016/j.resuscitation.2010.01.021 PubMed DOI

Dubus J‐C, Lê M‐S, Vitte J, et al. Use of epinephrine in emergency department depends on anaphylaxis severity in children. Eur J Pediatr. 2019;178:69‐75. 10.1007/s00431-018-3246-3 PubMed DOI

Sampson HA, Muñoz‐Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report – Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391‐397. 10.1016/j.jaci.2005.12.1303 PubMed DOI

Turner PJ, Worm M, Ansotegui IJ, et al. Time to revisit the definition and clinical criteria for anaphylaxis? World Allergy Organ J. 2019;12(10):100066. 10.1016/j.waojou.2019.100066 PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...